Technology Introduction:
EndoSemio's AI-powered ENT endoscope fuses narrow-band and white light imaging to highlight vascular changes linked to early nasopharyngeal cancer. Using a CNN+LSTM AI model trained on a large clinical database, it enables rapid, real-time identification of high-risk lesions—bringing advanced cancer screening to ENT clinics and reducing diagnostic delays.
Industry Applicability:
This technology enables ENT clinics to adopt AI-driven cancer screening without relying on expensive imaging infrastructure. By integrating real-time vascular analysis into standard ENT endoscopy, it lowers diagnostic barriers in high-risk regions. It supports early detection, reduces specialist workload, and accelerates industry adoption of intelligent diagnostic tools.